The early detection and treatment of cancer have progressively improved survival rates, yet the psychological impact on patients remains considerable. A meta-analysis has revealed that 11.6% of long-term cancer survivors suffer from significant depression, while 13.9% experience anxiety. When physical symptoms and psychological distress are not adequately managed, they are linked to poorer adherence to treatment, slower recovery times, diminished patient satisfaction, and increased healthcare costs. Recognizing the critical role of psychosocial care, many countries have incorporated it, often through distress screening, into their national cancer care frameworks. The International Psycho-Oncology Society (IPOS) and the World Health Organization (WHO) have established quality standards for cancer care, recognizing psychosocial care as a universal human right that should be accessible to all affected individuals. Achieving this goal requires the integration of psychosocial aspects into routine care. There is widespread agreement that implementing routine psychosocial assessment and management in clinical practice is challenging. The process is hindered by the complexity of addressing psychosocial distress. This presentation will explore the current advancements and successes in integrating psychosocial support into routine cancer care, emphasizing the challenges and complexities involved, and examining strategies to address these challenges.